B-Type Natriuretic Peptide and Arterial Stiffness in Healthy Japanese Men

American Journal of Hypertension

Volumn 19, Issue 5, 2006, Pages 443-447

  Yambe, Minoru ^a   Tomiyama, Hirofumi ^a   Koji, Yutaka ^a   Motobe, Kohki ^a   Shiina, Kazuki ^a   Gulnisia, Zaydun ^a   Yamamoto, Yoshio ^b   Yamashina, Akira ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b KAJIMA CORPORATION   (Japan)

Author keywords

Atherosclerosis; cardiovascular diseases; natriuretic peptide; pulse wave velocity

Indexed keywords

BIOCHEMICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGE DISTRIBUTION; ARTERY TONE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; IMMUNORADIOMETRIC ASSAY; JAPAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE PRESSURE; PULSE WAVE; STATISTICAL ANALYSIS;

AGED; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; HUMANS; IMMUNORADIOMETRIC ASSAY; JAPAN; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; REFERENCE VALUES; RISK FACTORS; VASCULAR RESISTANCE;

EID: 33646096960     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.08.004     Document Type: Article

References (29)

1. Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Omland T., Wolf P.A., and Vasan R.S. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (2004) 655-663
2. Magga J., Vuolteenaho O., Tokola H., Marttila M., and Ruskoaho H. Involvement of transcriptional and posttranscriptional mechanisms in cardiac overload-induced increase of B-type natriuretic peptide gene expression. Circ Res 81 (1997) 694-702
3. Nichols W.W., and O'Rourke M.F. Wave reflections. In: Nichols W.W., and O'Rourke M.F. (Eds). McDonald's Blood Flow in Arteries. Theoretical, Experimental and Clinical Principles. Fourth Edition (1998), London, Edward Arnold 203-222
4. Kingwell B.A., Waddell T.K., Medley T.L., Cameron J.D., and Dart A.M. Large artery stiffness predicts ischemic threshold in patients with coronary artery disease. J Am Coll Cardiol 40 (2002) 773-779
5. Laurent S., Boutouyrie P., Asmar R., Gautier I., Laloux B., Guize L., Ducimetiere P., and Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
6. London G.M., and Cohn J.N. Prognostic application of arterial stiffness. task forces. Am J Hypertens 15 (2002) 754-758
7. Benetos A., Waeber B., Izzo J., Mitchell G., Resnick L., Asmar R., and Safar M. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness. clinical applications. Am J Hypertens 15 (2002) 1101-1108
8. Oliver J.J., and Webb D.J. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol 23 (2003) 554-566
9. Franklin S.S., Khan S.A., Wong N.D., Larson M.G., and Levy D. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham Heart Study. Circulation 100 (1999) 354-360
10. Dart A.M., and Kingwell B.A. Pulse pressure-a review of mechanisms and clinical relevance. J Am Coll Cardiol 37 (2001) 975-984
11. Yamashina A., Tomiyama H., Takeda K., Tsuda H., Arai T., Hirose K., Koji Y., Hori S., and Yamamoto Y. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25 (2002) 359-364
12. Yambe M., Tomiyama H., Hirayama Y., Gulniza Z., Takata Y., Koji Y., Motobe K., and Yamashina A. Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens Res 27 (2004) 625-631
13. Cowie M.R., Jourdain P., Maisel A., Dahlstrom U., Follath F., Isnard R., Luchner A., McDonagh T., Mair J., Nieminen M., and Francis G. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 24 (2003) 1710-1718
14. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 24 (2003) 341-356
15. Heeschen C., Hamm C.W., Mitrovic V., Lantelme N.H., White H.D., and Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 110 (2004) 3206-3212
16. Nielsen O.W., McDonagh T.A., Robb S.D., and Dargie H.J. Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population. J Am Coll Cardiol 41 (2003) 113-120
17. Mitchell G.F., Parise H., Benjamin E.J., Larson M.G., Keyes M.J., Vita J.A., Vasan R.S., and Levy D. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women. the Framingham Heart Study. Hypertension 43 (2004) 1239-1245
18. Buckberg G.D., Fixler D.E., Archie J.P., and Hoffman J.I. Experimental subendocardial ischemia in dogs with normal coronary arteries. Circ Res 30 (1972) 67-81
19. Nichols W.W., and O'Rourke M.F. Coupling the left ventricle with systemic circulation. implications to cardiac failure. In: Nichols W.W., and O'Rourke M.F. (Eds). McDonald's Blood Flow in Arteries. Theoretical, Experimental and Clinical Principles. Fourth Edition. (1998), Edward Arnold, London 294-316
20. Ruck A., Gustafsson T., Norrbom J., Nowak J., Kallner G., Soderberg M., Sylven C., and Drvota V. ANP and BNP but not VEGF are regionally overexpressed in ischemic human myocardium. Biochem Biophys Res Commun 322 (2004) 287-291
21. Kass D.A. Age-related changes in venticular-arterial coupling. pathophysiologic implications. Heart Fail Rev 7 (2002) 51-62
22. Mehra M.R., Milani R.V., Richie M.B., Uber P.A., Park M.H., Ventura H.O., Scott R.L., and Lavie C.J. Ventricular-vascular uncoupling increases expression of B-type natriuretic peptide in heart transplantation. Transplant Proc 36 (2004) 3149-3151
23. van Popele N.M., Grobbee D.E., Bots M.L., Asmar R., Topouchian J., Reneman R.S., Hoeks A.P., van der Kuip D.A., Hofman A., and Witteman J.C. Association between arterial stiffness and atherosclerosis. the Rotterdam Study. Stroke 32 (2001) 454-460
24. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 (2003) 391-397
25. Blankenberg S., Rupprecht H.J., Poirier O., Bickel C., Smieja M., Hafner G., Meyer J., Cambien F., Tiret L., and AtheroGene Investigators. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107 (2003) 1579-1585
26. Yasmin, McEniery C.M., Wallace S., Mackenzie I.S., Cockcroft J.R., and Wilkinson I.B. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 24 (2004) 969-974
27. Tomiyama H., Arai T., Koji Y., Yambe M., Hirayama Y., Yamamoto Y., and Yamashina A. The relationship between high-sensitive C-reactive protein and pulse wave velocity in healthy Japanese men. Atherosclerosis 174 (2004) 373-377
28. Yasmin, Wallace S., McEniery C.M., Dakham Z., Pusalkar P., Maki-Petaja K., Ashby M.J., Cockcroft J.R., and Wilkinson I.B. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 25 (2005) 372-378
29. Schmitt M., Qasem A., McEniery C., Wilkinson I.B., Tatarinoff V., Noble K., Klemes J., Payne N., Frenneaux M.P., Cockcroft J., and Avolio A. Role of natriuretic peptides in regulation of conduit artery distensibility. Am J Physiol Heart Circ Physiol 287 (2004) H1167-H1171